Abeona Therapeutics Inc’s recent filing unveils that its Director Charles Faith L. acquired Company’s shares for reported $24764.0 on Apr 26 ’24. In the deal valued at $3.28 per share,7,550 shares were bought. As a result of this transaction, Charles Faith L. now holds 78,323 shares worth roughly $0.37 million.
Then, Seshadri Vishwas bought 10,000 shares, generating $32,000 in total proceeds. Upon buying the shares at $3.20, the Chief Executive Officer now owns 538,260 shares.
Before that, O’Malley Brendan M. bought 8,600 shares. Abeona Therapeutics Inc shares valued at $27,864 were divested by the SVP, General Counsel at a price of $3.24 per share. As a result of the transaction, O’Malley Brendan M. now holds 188,718 shares, worth roughly $0.9 million.
Cantor Fitzgerald upgraded its Abeona Therapeutics Inc [ABEO] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including B. Riley FBR’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. SVB Leerink began covering ABEO with “an Outperform” recommendation on February 10, 2020.
Price Performance Review of ABEO
On Monday, Abeona Therapeutics Inc [NASDAQ:ABEO] saw its stock jump 3.91% to $4.78. Over the last five days, the stock has gained 38.95%. Abeona Therapeutics Inc shares have fallen nearly -4.59% since the year began. Nevertheless, the stocks have risen 46.63% over the past one year. While a 52-week high of $9.01 was reached on 03/06/24, a 52-week low of $2.83 was recorded on 04/25/24. SMA at 50 days reached $6.90, while 200 days put it at $5.05. A total of 2.44 million shares were traded, compared to the trading of 0.76 million shares in the previous session.
Levels Of Support And Resistance For ABEO Stock
The 24-hour chart illustrates a support level at 4.49, which if violated will result in even more drops to 4.19. On the upside, there is a resistance level at 5.02. A further resistance level may holdings at 5.25. The Relative Strength Index (RSI) on the 14-day chart is 41.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.40, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.96%. Stochastics %K at 26.54% indicates the stock is a holding.
